(S) -Enitociclib

• Description:

  (S) -Enitociclib (VIP152) is a selective CDK9 inhibitor that induces complete regression of MYC+ lymphomas by inhibiting RNA polymerase II-mediated transcription of anti-apoptotic and pro-survival proteins.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  404.43

• Molecular Formula:

  C19H18F2N4O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK

• CAS Number:

  1610408-97-3